Related Articles
Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells
MicroRNA‑654‑3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells
Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts
Synergy between cisplatin and an inhibitor of S-adenosylmethionine dependent transmethylation in human ovarian adenocarcinoma cells